Lian B - Search Results

1

Multifactorial Analysis of Prognostic Factors and Survival Rates Among 706 Mucosal Melanoma Patients.

Cui C, Lian B, Zhou L, Song X, Zhang X, Wu D, Chi Z, Si L, Sheng X, Kong Y, Tang B, Mao L, Wang X, Li S, Dai J, Yan X, Bai X, Balch CM, Guo J. Cui C, et al. Among authors: lian b. Ann Surg Oncol. 2018 Aug;25(8):2184-2192. doi: 10.1245/s10434-018-6503-9. Epub 2018 May 10. Ann Surg Oncol. 2018. PMID: 29748886

2

The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients.

Lian B, Cui CL, Zhou L, Song X, Zhang XS, Wu D, Si L, Chi ZH, Sheng XN, Mao LL, Wang X, Tang BX, Yan XQ, Kong Y, Dai J, Li SM, Bai X, Zheng N, Balch CM, Guo J. Lian B, et al. Ann Oncol. 2017 Apr 1;28(4):868-873. doi: 10.1093/annonc/mdw694. Ann Oncol. 2017. PMID: 28039178 Free article.

3

Toripalimab (anti-PD-1) versus high-dose interferon-α2b as adjuvant therapy in resected mucosal melanoma: a phase II randomized trial.

Lian B, Si L, Chi ZH, Sheng XN, Kong Y, Wang X, Tian H, Li K, Mao LL, Bai X, Tang BX, Yan XQ, Li SM, Zhou L, Dai J, Tang XW, Ran FW, Yao S, Guo J, Cui CL. Lian B, et al. Ann Oncol. 2022 Oct;33(10):1061-1070. doi: 10.1016/j.annonc.2022.07.002. Epub 2022 Jul 14. Ann Oncol. 2022. PMID: 35842199 Free article. Clinical Trial.

4

A phase II, randomized, double-blind, placebo-controlled multicenter trial of Endostar in patients with metastatic melanoma.

Cui C, Mao L, Chi Z, Si L, Sheng X, Kong Y, Li S, Lian B, Gu K, Tao M, Song X, Lin T, Ren X, Qin S, Guo J. Cui C, et al. Among authors: lian b. Mol Ther. 2013 Jul;21(7):1456-63. doi: 10.1038/mt.2013.79. Epub 2013 May 14. Mol Ther. 2013. PMID: 23670576 Free PMC article. Clinical Trial.

5

Phase II randomized trial comparing high-dose IFN-α2b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma.

Lian B, Si L, Cui C, Chi Z, Sheng X, Mao L, Li S, Kong Y, Tang B, Guo J. Lian B, et al. Clin Cancer Res. 2013 Aug 15;19(16):4488-98. doi: 10.1158/1078-0432.CCR-13-0739. Epub 2013 Jul 5. Clin Cancer Res. 2013. PMID: 23833309 Clinical Trial.

6

Prognostic factors for conjunctival melanoma: a study in ethnic Chinese patients.

Sheng X, Li S, Chi Z, Si L, Cui C, Mao L, Lian B, Tang B, Wang X, Yan X, Kong Y, Dai J, Guo J. Sheng X, et al. Among authors: lian b. Br J Ophthalmol. 2015 Jul;99(7):990-6. doi: 10.1136/bjophthalmol-2014-305730. Epub 2015 Jan 16. Br J Ophthalmol. 2015. PMID: 25595173

7

Adjuvant therapy of mucosal melanoma.

Lian B, Guo J. Lian B, et al. Chin Clin Oncol. 2014 Sep;3(3):33. doi: 10.3978/j.issn.2304-3865.2014.08.01. Chin Clin Oncol. 2014. PMID: 25841459 Free article.

8

Checkpoint inhibitors in treatment of metastatic mucosal melanoma.

Lian B, Guo J. Lian B, et al. Chin Clin Oncol. 2014 Sep;3(3):37. doi: 10.3978/j.issn.2304-3865.2014.07.05. Chin Clin Oncol. 2014. PMID: 25841463 Free article.

9

GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis.

Sheng X, Kong Y, Li Y, Zhang Q, Si L, Cui C, Chi Z, Tang B, Mao L, Lian B, Wang X, Yan X, Li S, Dai J, Guo J. Sheng X, et al. Among authors: lian b. Eur J Cancer. 2016 Sep;65:156-63. doi: 10.1016/j.ejca.2016.06.019. Epub 2016 Aug 4. Eur J Cancer. 2016. PMID: 27498141

10

MAPK Pathway and TERT Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 Cases.

Bai X, Kong Y, Chi Z, Sheng X, Cui C, Wang X, Mao L, Tang B, Li S, Lian B, Yan X, Zhou L, Dai J, Guo J, Si L. Bai X, et al. Among authors: lian b. Clin Cancer Res. 2017 Oct 15;23(20):6120-6127. doi: 10.1158/1078-0432.CCR-17-0980. Epub 2017 Jul 18. Clin Cancer Res. 2017. PMID: 28720667

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

572 results

Search Page

Filters